POLYTHÉRAPIE POUR LE CANCER À L'AIDE D'ANTICORPS ANTI-GITR

• 收藏
• 分享

专利权人:

Five Prime Therapeutics; Inc.

发明人:

申请号：

EP18718990.7

公开号：

EP3601353A1

申请日:

2018.03.29

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Provided herein are methods of treating cancer with a combination of an anti glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR)-antibody and an antibody that binds colony stimulating factor 1 receptor (CSF1R) or with a combination of an anti-GITR antibody and an antibody that binds programmed cell death protein 1 (PD-1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/